Àá½Ã¸¸ ±â´Ù·Á ÁÖ¼¼¿ä. ·ÎµùÁßÀÔ´Ï´Ù.

ÆÄŲ½¼¾¾º´¿¡ ´ëÇÑ ³úÁ¤À§Àû ½Ã»óÇÙÆı«¼ú ¹× ´ãⱸÀýÁ¦¼ú Treatment of Parkinson's Disease by Streotactic Thalamotomy and Pallidotomy

´ëÇѽŰæ¿Ü°úÇÐȸÁö 1997³â 26±Ç 3È£ p.313 ~ 319
¼Ò¼Ó »ó¼¼Á¤º¸
Á¶¼ºÈ¯/Sung Whan Cho ±è¹®Âù/°­Áرâ/À̸í±â/±è´ëÁ¶/Moon Chan Kim/Joon Ki Kang/Myeong Ki Lee/Dae Jo Kim

Abstract

¼­ ·Ð
ÁøÀü(tremor), °æÁ÷(rigidity), ¼­µ¿(bradykinesia)µîÀÇ ÁÖ Áõ»óÀ» º¸ÀÌ´Â ÆÄŲ½¼¾¾º´
(Parkinson's disease)Àº ¹Ì±¹¿¡¼­´Â °¡Àå ¸¹Àº À¯º´·üÀ» °¡Áø ½Å°æ ÅðÇ༺ Áúȯ Áß Çϳª·Î
¹é ¸¸¸í ÀÌ»óÀÌ ÁúȯÀ¸·Î °íÅëÀ» ¹Þ°í ÀÖ´Ù. ¿ì¸® ³ª¶ó¿¡¼­´Â Á¤È®ÇÑ À¯º´·üÀº ¾Ë·ÁÁöÁö ¾Ê
¾ÒÁö¸¸, ÃÖ±Ù °æÁ¦ ¼ºÀå°ú ¹®È­ ¼öÁØÀÇ Çâ»óÀ¸·Î ³ë·ÉÃþÀÇ Áõ°¡¿Í ´õºÒ¾î ¹ßº´·üÀÌ Áõ°¡ Ãß
¼¼¿¡ ÀÖ´Ù°í ¿©°ÜÁø´Ù.
¿¤µµÆÄ(levodopa)°¡ 25³â ÀÌ»ó ¾à¹° ¿ä¹ýÀÇ ±Ù°£À» ÀÌ·ç¾î ¿ÔÀ¸³ª, ´ë´Ù¼ö ȯÀÚµéÀÌ ¾à¹°
¿¡ ´ëÇÑ ºÎÀÛ¿ëÀ» °ÞÀ¸¸ç ¾à¹° º¹¿ë 5³â À̳»¿¡ ¿¤µµÆÄ¿¡ ´ëÇÑ ¹ÝÀÀÀÌ °¨¼ÒµÇ´Â °æÇèÀ» ÇÏ
°í ÀÖ´Ù. ÀÌ »ç½Ç°ú ´õºÒ¾î ½Å°æ ¹æ»ç¼± ¿µ»ó, ½Å°æ »ý¸®ÇÐÀû °¨½ÃÀåÄ¡, ³úÁ¤À§Àû ¼ö¼ú ±â±¸
¿Í ¼ö¼ú ¼ú±â µîÀÇ ¹ß´Þ°ú ½Ã»óºÎ ¹× ³ú±âÀúÇÙºÎÀÇ ½Å°æ ÇغÎÇÐÀû ¿¬±¸¿¡ ÈûÀÔ¾î ÆÄŲ½¼¾¾
º´ Ä¡·á¿¡ ´ëÇÑ ±â´ÉÀû ³úÁ¤À§Àû ½Ã¼ú¿¡ ´ëÇÑ ±â´ë°¡ Á¡Â÷ÀûÀ¸·Î Ä¿Áö°í ÀÖ´Ù.
ÆÄŲ½¼¾¾º´ÀÇ ³úÁ¤À§Àû ¼ö¼úÀº 1955³â Hassler°¡ ¿îµ¿°æ·ÎÀÇ Á¤°ÅÀå ¿ªÇÒÀ» ÇÏ´Â ½Ã»óÇÙ
ÀÇ º´¸®»ý¸®ÇÐÀû ±âÀüÀ» ¹ßÇ¥ÇÑ µÚ, ½Ã»óÇÙÀ» ÅëÇÑ Ç×ÁøµÈ ¿îµ¿°æ·Î¸¦ Â÷´ÜÇÏ´Â º¹¿ÜÃø ½Ã
»óÆı«¼ú(ventrolateral thalamotomy)À» ¼Ò°³ÇÑ ÀÌ·¡·Î, ÇöÀç±îÁöµµ ¸¹ÀÌ ½Ã¼úµÇ°í ÀÖÀ¸¸ç,
ÃÖ±Ù¿¡´Â º´Å»ý¸®ÇÐÀû ±âÀüÀÌ ¹àÇôÁö¸é¼­ ÈÄ¿ÜÃø ´ãⱸÀýÁ¦¼ú(posterola-terat
pallidotomy)ÀÌ ¼Ò°³µÇ¾î ÆÄŲ½¼º´ÀÇ ³úÁ¤À§Àû ¼ö¼ú ¹æ¹ýÀ¸·Î¼­ °¢±¤À» ¹Þ°í ÀÖ´Ù.
º» ±³½Ç¿¡¼­´Â ÃÖ±Ù 10³â°£ ¼ö¼ú Ä¡ÇèÇÑ ÆÄŲ½¼¾¾º´¿¡ ´ëÇÑ ³úÁ¤À§Àû º¹¿ÜÃø ½Ã»óÆı«¼ú
¹× ÈÄ¿ÜÃø ´ãⱸÀýÁ¦¼úÀÇ °æÇè°ú °á°ú¸¦ ºÐ¼®ÇÏ°í, ±× ¿ªÇÒÀ» ¾Ë¾Æº¸°íÀÚ ÇÑ´Ù.
#ÃÊ·Ï#
The authors report the surgical results of thalamotomy and pallidotomy, performed at
out hospital between 1983 and 1993 for the treatment of Parkinson's disease. The series
included a retrospective analysis of 156 patients with this condition by stereotactic
ventrolateral(VL) thalamotomy(126 patients, 138 thalamotomies) and posterolateral
pallidotomy(30 patients, 30 pallidotomies). Each patient was followed up postoperatively,
for one year. Among those who underwent the stereotactic VL thalamotomy, 136/138
procedures(99%) let to improvement of tumor, and 83/138(60%) resulted in reduced
rigidity. Stereotactic posterolateral pallidotomy, led to improvement of bradykinesia after
27/30 procedures(90%), of rigidity after 22.30(73%) and of tremor after 13/30(43%). Drug
induced dyskinesia showed a 42% improvement in the thalamotomy series and a 93%
improvement in the pallidotomy serious ; the difference between the two series was
significant(P<0.001). The patients themselves and their relatives used the Hoehn & Yahr
staging scale to assess postoperative improvement in disability, and according to the
results, 91/126 patients(72%) in the thalamotomy series and 26/30(87%) in the
pallidotomy series showed improvement. In the thalamotomy series, there was no
statistically significantly higher improvement in diability for preoperative groups I and ¥±
(Hoehn & Yahr staging scale) than for groups ¥² and ¥³(P<0.029), while in the
pallidotomy series, there was no statistically significant difference in postoperative
improvement between these same groups (P>0.557). In addition, for groups with greater
preoperative disability(Hoehn & Yahr staging, groups ¥² and ¥³), improvement was more
likely after pallidotomy than after thalamotomy. In the pallidotomy series, dysphasia was
the only serious complication and this was seen after 20% of procedures. In the
thalamotomy series, however, complications included hypotonia(24%), transient
confusion(19%), transient dysphasia(11%), permanent dysarthria(7%), subjective
numbness(4%) and epileptic seizure(3%).
The authors believe that posterolateral pallidotomy is much more effective than VL
thalamotomy for the control of Parkinson bradykinesia and rigidty, but that thalamotomy
is still a useful surgical option for the control of Parkinsonian tremor.

Å°¿öµå

Stereotactic thalamotomy; Sterotactic pallidotomy; Hoehn & Yahr staging scale; Parkinson's disease.;

¿ø¹® ¹× ¸µÅ©¾Æ¿ô Á¤º¸

 

µîÀçÀú³Î Á¤º¸

KoreaMed
KAMS